163 related articles for article (PubMed ID: 28425041)
21. A case of late onset cardiac amyloidosis with a new transthyretin variant (lysine 92).
Saito F; Nakazato M; Akiyama H; Kitahara Y; Date Y; Iwasaki Y; Harasawa S; Hisaki R; Horie T; Kinukawa N; Watanabe T; Sakamaki T; Yagi H; Hoshii Y; Yutani C; Kanmatsuse K
Hum Pathol; 2001 Feb; 32(2):237-9. PubMed ID: 11230714
[TBL] [Abstract][Full Text] [Related]
22. Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men.
Jacobson D; Tagoe C; Schwartzbard A; Shah A; Koziol J; Buxbaum J
Am J Cardiol; 2011 Aug; 108(3):440-4. PubMed ID: 21600538
[TBL] [Abstract][Full Text] [Related]
23. Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.
Fradley MG; Thakuria JV; Collins AB; Moore SA; Stone JR
Tex Heart Inst J; 2012; 39(1):71-5. PubMed ID: 22412233
[TBL] [Abstract][Full Text] [Related]
24. A transthyretin variant, Asp18Asn, associated with amyloid cardiomyopathy: a new African-American variant?
Quarta CC; Falk RH
Amyloid; 2012 Dec; 19(4):204-7. PubMed ID: 23126592
[TBL] [Abstract][Full Text] [Related]
25. The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation.
Ammirati E; Marziliano N; Vittori C; Pedrotti P; Bramerio MA; Motta V; Orsini F; Veronese S; Merlini PA; Martinelli L; Frigerio M
Amyloid; 2012 Jun; 19(2):113-7. PubMed ID: 22449240
[TBL] [Abstract][Full Text] [Related]
26. Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis.
Gustafsson S; Ihse E; Henein MY; Westermark P; Lindqvist P; Suhr OB
Transplantation; 2012 May; 93(10):1017-23. PubMed ID: 22395298
[TBL] [Abstract][Full Text] [Related]
27. [Hereditary amyloid cardiomyopathy related to a mutation at transthyretin protein number 111. A clinical, genetic and echocardiographic study of an affected Danish family].
Svendsen IH; Steensgaard-Hansen F; Nordvåg BY
Ugeskr Laeger; 1999 Sep; 161(36):4995-9. PubMed ID: 10489791
[TBL] [Abstract][Full Text] [Related]
28. Transthyretin-related amyloidoses and the heart: a clinical overview.
Rapezzi C; Quarta CC; Riva L; Longhi S; Gallelli I; Lorenzini M; Ciliberti P; Biagini E; Salvi F; Branzi A
Nat Rev Cardiol; 2010 Jul; 7(7):398-408. PubMed ID: 20479782
[TBL] [Abstract][Full Text] [Related]
29. Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
Gustavsson S; Granåsen G; Grönlund C; Wiklund U; Mörner S; Henein M; Suhr OB; Lindqvist P
Amyloid; 2015; 22(3):163-70. PubMed ID: 26104852
[TBL] [Abstract][Full Text] [Related]
30. Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy.
Christoph DC; Boese D; Johnson KT; Schlosser TW; Hunold P; Baba HA; Erbel R; Philipp S
Circ Heart Fail; 2009 Sep; 2(5):512-5. PubMed ID: 19808383
[No Abstract] [Full Text] [Related]
31. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Yazaki M; Tokuda T; Nakamura A; Higashikata T; Koyama J; Higuchi K; Harihara Y; Baba S; Kametani F; Ikeda S
Biochem Biophys Res Commun; 2000 Aug; 274(3):702-6. PubMed ID: 10924339
[TBL] [Abstract][Full Text] [Related]
32. Cardiomyopathy in Swedish patients with the Gly53Glu and His88Arg transthyretin variants.
Holmgren G; Hellman U; Anan I; Lundgren HE; Jonasson J; Stafberg C; Fahoum S; Suhr OB
Amyloid; 2005 Sep; 12(3):184-8. PubMed ID: 16194874
[TBL] [Abstract][Full Text] [Related]
33. Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis.
Jin K; Sato S; Takahashi T; Nakazaki H; Date Y; Nakazato M; Tominaga T; Itoyama Y; Ikeda S
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1463-6. PubMed ID: 15377697
[TBL] [Abstract][Full Text] [Related]
34. A new ATTR Phe64Ile mutation with late-onset multiorgan involvement.
Tarquini R; Perfetto F; Bergesio F; Miliani A; Del Pace S; Frusconi S; Minuti B; Pelo E; Torricelli F
Amyloid; 2007 Dec; 14(4):289-92. PubMed ID: 17968689
[TBL] [Abstract][Full Text] [Related]
35. Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.
Maurer MS; Grogan DR; Judge DP; Mundayat R; Packman J; Lombardo I; Quyyumi AA; Aarts J; Falk RH
Circ Heart Fail; 2015 May; 8(3):519-26. PubMed ID: 25872787
[TBL] [Abstract][Full Text] [Related]
36. Isolated cardiac involvement in primary amyloidosis: presenting as sick sinus syndrome and heart failure.
Pattanshetty DJ; Bhat PK; Chamberlain WA; Lyons MR
Tex Heart Inst J; 2013; 40(5):615-8. PubMed ID: 24391340
[TBL] [Abstract][Full Text] [Related]
37. Extremely early onset hereditary ATTR amyloidosis with G47R (p.G67R) mutation.
Kobayashi Y; Sekijima Y; Ogawa Y; Kondo Y; Miyazaki D; Ikeda SI
Amyloid; 2016 Sep; 23(3):205-206. PubMed ID: 27206384
[No Abstract] [Full Text] [Related]
38. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.
Gagliardi C; Perfetto F; Lorenzini M; Ferlini A; Salvi F; Milandri A; Quarta CC; Taborchi G; Bartolini S; Frusconi S; Martone R; Cinelli MM; Foffi S; Reggiani MLB; Fabbri G; Cataldo P; Cappelli F; Rapezzi C
Eur J Heart Fail; 2018 Oct; 20(10):1417-1425. PubMed ID: 30070416
[TBL] [Abstract][Full Text] [Related]
39. [Familial transthyretin amyloidosis].
Pogromov AP; Diukova GM; Kovalchuk MO; Strokov IA; Akhmedzhanova LT; Generozov EV; Markin SS
Klin Med (Mosk); 2009; 87(11):67-71. PubMed ID: 20143571
[TBL] [Abstract][Full Text] [Related]
40. Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.
Jacobson DR; Ittmann M; Buxbaum JN; Wieczorek R; Gorevic PD
Tex Heart Inst J; 1997; 24(1):45-52. PubMed ID: 9068139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
